Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC2A3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ACP6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GAS7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100128909 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZNF404 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPM6B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERO1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIO - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C4orf47 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRRK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BSPRY - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABHD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC2A14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM19A5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARVB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BFSP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100507472 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLDC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on